series-a
Stage
1
Investors
About
Lungpacer develops the AeroPace System, a temporary transvenous diaphragm neurostimulation device designed to activate the diaphragm to restore independent breathing and improve ventilator weaning in mechanically ventilated patients.
Explore Lungpacer's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.